Repository of Research and Investigative Information

Repository of Research and Investigative Information

Shahid Sadoughi University of Medical Sciences

Pharmacological treatments of COVID-19

(2020) Pharmacological treatments of COVID-19. Pharmacological Reports. pp. 1446-1478. ISSN 1734-1140

Full text not available from this repository.

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19), which was reported for the first time in December 2019, was named by the World Health Organization (WHO) as Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV2), because of the very similar genome and also its related symptoms to SARS-CoV1. The ongoing COVID-19 pandemic with significant mortality, morbidity, and socioeconomic impact is considered by the WHO as a global public health emergency. Since there is no specific treatment available for SARS-CoV2 infection, and or COVID-19, several clinical and sub-clinical studies are currently undertaken to find a gold-standard therapeutic regimen with high efficacy and low side effect. Based on the published scientific evidence published to date, we summarized herein the effects of different potential therapies and up-to-date clinical trials. The review is intended to help readers aware of potentially effective COVID-19 treatment and provide useful references for future studies.

Item Type: Article
Keywords: COVID-19 Pharmacology Pneumonia SARS-CoV2 respiratory syndrome coronavirus host gene-expression corticosteroid treatment 2019-novel coronavirus rheumatoid-arthritis eculizumab treatment clinical-efficacy interferon-alpha sars ribavirin Pharmacology & Pharmacy
Page Range: pp. 1446-1478
Journal or Publication Title: Pharmacological Reports
Journal Index: WoS
Volume: 72
Number: 6
Identification Number: https://doi.org/10.1007/s43440-020-00152-9
ISSN: 1734-1140
Depositing User: Mr mahdi sharifi
URI: http://eprints.ssu.ac.ir/id/eprint/30656

Actions (login required)

View Item View Item